Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston
6
×
boston blog main
boston top stories
national blog main
life sciences
deals
national top stories
san francisco blog main
fda
investing
medical devices
san diego blog main
san francisco top stories
startups
clinical trials
dna
new york blog main
san diego top stories
vc
venture capital
agios therapeutics
arrowmark partners
atrial fibrillation
azacitidine
base editing
bay state health
beta bionics
beta-thalassemia
bigfoot biomedical
biofourmis
biovotion
boston scientific
boston university
branden moriarty
broad institute
cas13
cedars-sinai medical center
censinet
chugai pharmaceutical
What
startup
6
×
therapeutics
boston
developing
device
million
patients
acquire
adding
aims
analytics
approach
atrial
based
beam
beta
biofourmis
bionics
biotech
blood
business
called
cas
censinet
closed
continues
crispr
cryterion
cyber
data
deal
debuts
devices
diabetes
digital
driven
drugs
editas
editing
editor
Language
unset
Current search:
biotech
×
startup
×
boston
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Censinet Takes Off With $7.8M to Track Cyber Risks in Healthcare
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M